Hypertrophic and antihypertrophic microRNA levels in peripheral blood mononuclear cells and their relationship to left ventricular hypertrophy in patients with essential hypertension

Journal of the American Society of Hypertension

Volumn 9, Issue 10, 2015, Pages 802-810

  Kontaraki, Joanna E ^a   Marketou, Maria E ^b   Parthenakis, Fragiskos I ^b   Maragkoudakis, Spyros ^b   Zacharis, Evangelos A ^b   Petousis, Stelios ^b   Kochiadakis, George E ^b   Vardas, Panos E ^b  

^a UNIVERSITY OF CRETE   (Greece)

^b UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

Left ventricular mass index; miR 1; miR 133a; miR 208b; miR 21; miR 26b; miR 499

Indexed keywords

MICRORNA; MICRORNA 1; MICRORNA 133A; MICRORNA 208B; MICRORNA 21; MICRORNA 26B; MICRORNA 499; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; MIRN1 MICRORNA, HUMAN; MIRN133 MICRORNA, HUMAN; MIRN208 MICRORNA, HUMAN; MIRN21 MICRORNA, HUMAN; MIRN26A MICRORNA, HUMAN; MIRN499 MICRORNA, HUMAN;

ADULT; ARTICLE; CARDIOVASCULAR RISK; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETES MELLITUS; ESSENTIAL HYPERTENSION; FEMALE; GENE EXPRESSION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PREVALENCE; PRIORITY JOURNAL; TWO DIMENSIONAL ECHOCARDIOGRAPHY; AGED; BLOOD; COMPLICATION; ECHOGRAPHY; GENE EXPRESSION PROFILING; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AGED; BIOMARKERS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; LEUKOCYTES, MONONUCLEAR; MALE; MICRORNAS; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84945438814     PISSN: 19331711     EISSN: 18787436     Source Type: Journal    
DOI: 10.1016/j.jash.2015.07.013     Document Type: Article

References (39)

1. S.M. Stevens, K. Reinier, and S.S. Chugh Increased left ventricular mass as a predictor of sudden cardiac death: is it time to put it to the test? Circ Arrhythm Electrophysiol 6 1 2013 212 217
2. A.V. Chobanian, G.L. Bakris, H.R. Black, W.C. Cushman, L.A. Green, J.L. Izzo, and et al. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure Hypertension 42 6 2003 1206 1252
3. E. Frohlich, C. Apstein, A. Chobanian, R. Devereux, H. Dustan, V. Dzau, and et al. The heart in hypertension N Engl J Med 3 27 1992 998 1008
4. S. Perlini, and G. Grassi Hypertension-related target organ damage: is it a continuum? J Hypertens 31 6 2013 1083 1085
5. D.B. Tulman, S.P. Stawicki, T.J. Papadimos, C.V. Murphy, and S.D. Bergese Advances in management of acute hypertension: a concise review Discov Med 13 72 2012 375 383
6. C. Cuspidi, M. Rescaldani, C. Sala, F. Negri, G. Grassi, and G. Mancia Prevalence of electrocardiographic left ventricular hypertrophy in human hypertension: an updated review J Hypertens 30 11 2012 2066 2073
7. M. Bombelli, R. Facchetti, S. Carugo, F. Madotto, F. Arenare, F. Quarti-Trevano, and et al. Left ventricular hypertrophy increases cardiovascular risk independently of in-office and out-of-office blood pressure values J Hypertens 27 12 2009 2458 2464
8. M. Abdellatif Differential expression of microRNAs in different disease states Circ Res 110 4 2012 638 650
9. E.M. Small, and E.N. Olson Pervasive roles of microRNAs in cardiovascular biology Nature 469 7330 2011 336 342
10. G. Condorelli, M.V. Latronico, and E. Cavarretta microRNAs in cardiovascular diseases: current knowledge and the road ahead J Am Coll Cardiol 63 21 2014 2177 2187
11. K.C. Vickers, K.A. Rye, and F. Tabet MicroRNAs in the onset and development of cardiovascular disease Clin Sci (Lond) 126 3 2014 183 194
12. E. van Rooij, and S. Kauppinen Development of microRNA therapeutics is coming of age EMBO Mol Med 6 7 2014 851 864
13. P.A. Da Costa Martins, and L.J. De Windt MicroRNAs in control of cardiac hypertrophy Cardiovasc Res 93 4 2012 563 572
14. G. Mancia, G. De Backer, A. Dominiczak, R. Cifkova, R. Fagard, G. Germano, and et al. 2007 Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) J Hypertens 25 6 2007 1105 1187
15. R.M. Lang, M. Bierig, R.B. Devereux, F.A. Flachskampf, E. Foster, P.A. Pellikka, and et al. Recommendations for chamber quantification Eur J Echocardiogr 7 2 2006 79 108
16. N. Schiller, P. Shah, M. Crawford, A. DeMaria, R. Devereux, H. Feigenbaum, and et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms J Am Soc Echocardiogr 2 5 1989 358 367
17. R. Devereux, and N. Reichek Echocardiographic determination of left ventricular mass in man: anatomic validation of the method Circulation 55 1977 613 618
18. G. Mancia, R. Fagard, K. Narkiewicz, J. Redon, A. Zanchetti, M. Bohm, and et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) J Hypertens 31 7 2013 1281 1357
19. J. Fiedler, and T. Thum MicroRNAs in myocardial infarction Arterioscler Thromb Vasc Biol 33 2 2013 201 205
20. R. Kumarswamy, and T. Thum Non-coding RNAs in cardiac remodeling and heart failure Circ Res 113 6 2013 676 689
21. J.E. Kontaraki, M.E. Marketou, E.A. Zacharis, F.I. Parthenakis, and P.E. Vardas MicroRNA-9 and microRNA-126 expression levels in patients with essential hypertension: potential markers of target-organ damage J Am Soc Hypertens 8 6 2014 368 375
22. J.E. Kontaraki, M.E. Marketou, E.A. Zacharis, F.I. Parthenakis, and P.E. Vardas Differential expression of vascular smooth muscle-modulating microRNAs in human peripheral blood mononuclear cells: novel targets in essential hypertension J Hum Hypertens 28 8 2014 510 516
23. P. Wen, D. Song, H. Ye, X. Wu, L. Jiang, B. Tang, and et al. Circulating miR-133a as a biomarker predicts cardiac hypertrophy in chronic hemodialysis patients PLoS One 9 10 2014 e103079
24. R. Garcia, A.V. Villar, M. Cobo, M. Llano, R. Martin-Duran, M.A. Hurle, and et al. Circulating levels of miR-133a predict the regression potential of left ventricular hypertrophy after valve replacement surgery in patients with aortic stenosis J Am Heart Assoc 2 4 2013 e000211
25. C. Liebetrau, H. Mollmann, O. Dorr, S. Szardien, C. Troidl, M. Willmer, and et al. Release kinetics of circulating muscle-enriched microRNAs in patients undergoing transcoronary ablation of septal hypertrophy J Am Coll Cardiol 62 11 2013 992 998
26. M. Han, Z. Yang, D. Sayed, M. He, S. Gao, L. Lin, and et al. GATA4 expression is primarily regulated via a miR-26b-dependent post-transcriptional mechanism during cardiac hypertrophy Cardiovasc Res 93 4 2012 645 654
27. Z.H. Zhang, J. Li, B.R. Liu, C.F. Luo, Q. Dong, L.N. Zhao, and et al. MicroRNA-26 was decreased in rat cardiac hypertrophy model and may be a promising therapeutic target J Cardiovasc Pharmacol 62 3 2013 312 319
28. B. Icli, P. Dorbala, and M.W. Feinberg An emerging role for the miR-26 family in cardiovascular disease Trends Cardiovasc Med 24 6 2014 241 248
29. J.E. Kontaraki, M.E. Marketou, E.A. Zacharis, F.I. Parthenakis, and P.E. Vardas Early cardiac gene transcript levels in peripheral blood mononuclear cells in patients with untreated essential hypertension J Hypertens 29 4 2011 791 797
30. V. Kinet, J. Halkein, E. Dirkx, and L.J. Windt Cardiovascular extracellular microRNAs: emerging diagnostic markers and mechanisms of cell-to-cell RNA communication Front Genet 4 2013 214
31. S. Das, and M.K. Halushka Extracellular vesicle microRNA transfer in cardiovascular disease Cardiovasc Pathol 24 4 2015 199 206
32. E. van Rooij, D. Quiat, B.A. Johnson, L.B. Sutherland, X. Qi, J.A. Richardson, and et al. A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance Dev Cell 17 5 2009 662 673
33. P. Chaturvedi, and S.C. Tyagi Epigenetic mechanisms underlying cardiac degeneration and regeneration Int J Cardiol 173 1 2014 1 11
34. M.F. Corsten, R. Dennert, S. Jochems, T. Kuznetsova, Y. Devaux, L. Hofstra, and et al. Circulating microRNA-208b and microRNA-499 reflect myocardial damage in cardiovascular disease Circ Cardiovasc Genet 3 6 2010 499 506
35. F. Olivieri, R. Antonicelli, M. Lorenzi, Y. D'Alessandra, R. Lazzarini, G. Santini, and et al. Diagnostic potential of circulating miR-499-5p in elderly patients with acute non ST-elevation myocardial infarction Int J Cardiol 167 2 2013 531 536
36. S.J. Matkovich, Y. Hu, W.H. Eschenbacher, L.E. Dorn, and G.W. Dorn 2nd Direct and indirect involvement of microRNA-499 in clinical and experimental cardiomyopathy Circ Res 111 5 2012 521 531
37. E.D. Frohlich, A. Gonzalez, and J. Diez Hypertensive left ventricular hypertrophy risk: beyond adaptive cardiomyocytic hypertrophy J Hypertens 29 1 2011 17 26
38. C. Cuspidi, C. Sala, F. Negri, G. Mancia, and A. Morganti Prevalence of left-ventricular hypertrophy in hypertension: an updated review of echocardiographic studies J Hum Hypertens 26 6 2012 343 349
39. C. Fernández-Hernando, C.M. Ramírez, L. Goedeke, and Y. Suárez MicroRNAs in metabolic disease Arterioscler Thromb Vasc Biol 33 2 2013 178 185